To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with JavaScript enabled.
This website is not optimized for your browser, as configured.

Listen to the youth voice for patient-centric pediatric drug development

ListenToTheYouthVoiceForPatientCentricPediatricDrugDevelopment FeatureImage 21Sept2020-01

Editor's Note: Courtney Tate is a Senior Clinical Research Scientist in the Pediatric Capabilities Function supporting pediatric research at Eli Lilly and Company. Courtney obtained her bachelor’s degrees in chemistry and molecular biology from the University of Indianapolis and doctoral degree in biochemistry and molecular biology from Indiana University School of Medicine.

CMT picture

One of the best ways to become more patient-centric is to hear directly from the people who may eventually use our medicines. This includes getting input from youth for pediatric research. What is important to them? What would make their life better? How could we improve the medicines, materials, devices, trial designs, and apps that they will be using or taking part in?

In the past few years, key stakeholders in drug development and research (advocacy groups, patients/caregivers, clinicians, industry, and regulatory agencies) have been advocating for pharmaceutical companies to become more patient-centric, so much so that the FDA has a Patient-Focused Drug Development effort that includes developing a series of four patient-focused drug development guidance documents. These documents address how stakeholders can collect and submit patient experience data and other relevant patient information for medical product development and regulatory decision making.

iCAN works to bring patient-centricity to pediatric drug development

International Children’s Advisory Network, Inc. (iCAN), is a worldwide consortium of children’s advisory groups, known as Kids Impacting Disease Through Science (KIDS) and Young Persons Advisory Groups (YPAGS). These dedicated youth member groups work in unison around the world to provide a voice for children and families in medicine, research, and innovation. iCAN members express their desire to be part of something bigger than themselves and to make a difference through meaningful contributions in the lives of children and youth living with a medical condition. iCAN members voice their true opinions, needs, ideas and experiences which enables their voices to matter, be understood, and be valued.

Over the past few years, Lilly and iCAN have collaborated in person at the iCAN Annual Summit and virtually on numerous projects to gain insightful input from youth to ensure we are creating patient-facing materials that are age-appropriate, comprehensible, and useful to the child and caregiver/parent. For example, we’ve obtained feedback and perspectives from iCAN youth on educational and trial materials: a training brochure for pill swallowing, a placebo response video, Understanding Clinical Trials Comic Books, and our assent templates or documents for youth to give permission to participate in research. In addition, we’ve gotten iCAN youth input on device preferences, level of comfort, and their innovative ideas around continuous data collection in clinical trials, as well as vital information to guide our age-appropriate formulation strategies.

We also want to make sure we design trials that are feasible and are really measuring what is important to the youth and their family. They are the experts on what it is like to live with their condition, so when you listen to their perspective, you get a small glimpse into their life. Research for children is complicated for many reasons, which is all the more reason to ensure we get youth input when possible. I remember one young man with Duchenne Muscular Dystrophy who shared that he didn’t care about the standard 6-minute walk test, which measures how far he could walk in 6 minutes. Rather, he cared about being able to put his shirt on, hold his own glass and toast with his friends, and get from his desk to his bed.

The iCAN youth are a true inspiration. Their stories are both heart-wrenching and motivational and stick with me long after I hear them. These youth are dedicated, driven, extremely bright, and never cease to amaze me with their creativity and unique concepts. I can’t say enough about the invaluable partnership with iCAN. The youth voices are critical to pediatric drug development and research.

I hate to admit it has been over 20 years since I was a child. Of course, I’ve gained experience along the way to approaching middle age, but I’ve also lost the way I used to think and feel as a child. The world in which our children are growing up is so different from the world I grew up in, or that my parents and grandparents grew up in. In order to stay current and tailor the way we approach pediatric drug development, we have to listen and respond to what the youth and parents/caregivers are telling us. Just like raising children takes a village, it takes all of us working together - the patients/parents/caregivers/families, industry, clinicians, advocacy groups, and regulators - to be successful in achieving Lilly’s purpose of uniting caring with discovery to create medicines that make life better for people around the world.

Tags: Patient Stories,

Recent Articles

ListenToTheYouthVoiceForPatientCentricPediatricDrugDevelopment FeatureImage 21Sept2020-01

Listen to the youth voice for patient-centric pediatric drug development

LTGBlogAuthors LillyGuestAuthorIcon 20July2018
Lilly Guest Author
September 24th, 20204 minute read

The patient voice is critical for successful clinical research, for people of all ages. Learn how Lilly’s partnership with iCAN helps us include that voice in research.

LeapingIntoDecentralizedClinicalTrials FeatureImage 16Sept2020-01

Leaping into Decentralized Clinical Trials

LTGBlogAuthors GuestAuthorIcon 20July2018
Guest Author
September 17th, 20203 minute read

Before starting medical school, Iman Mahoui joined Lilly’s Decentralized Trials team. She reflects on how new approaches to research can help address social justice and health equity issues.

MasterProtocol FeatureImage 14July2020-01

Platform Trials and Master Protocols: A New Approach to Clinical Research

Leigh Anne Naas Headshot
Leigh Anne Naas
August 18th, 20205 minute read

Learn more about platform trials and master protocols, an alternative model to how we conduct clinical research.

FindingTreatmentsTogether1 FeatureImage 22July2020

Finding Treatments Together: Part I

Leigh Anne Naas Headshot
Leigh Anne Naas
July 27th, 20205 minute read

Watch the first video in CISCRP's "Finding Treatments Together" series for a helpful outline of the clinical research process and what motivates people to participate.

10ThingstoKnowaboutClinicalTrialsAdapted FeatureImage 14Jun2019-01

10 Clinical Trial Facts You Should Know

Leigh Anne Naas Headshot
Leigh Anne Naas
July 22nd, 20201 minute read

If you’re a participant or caregiver looking for clinical trial information, it can be helpful to start with a basic overview. The infographic below provides 10 clinical trials facts you need to know.